#Spirometer market size

[tamanna31]

Digital Health Market Segmentation, Parameters and Prospects 2024 to 2030 Industry Research Report

Digital Health Industry Overview

The global digital health market size was estimated at USD 240.9 billion in 2023 and is projected to grow at a compound annual growth (CAGR) of 21.9% from 2024 to 2030. The market is driven by several factors, such as a strong domestic market for telehealthcare platform developers, mHealth app providers, wearable device manufacturers, and e-prescription systems.

Moreover, the healthcare industry exhibits high growth potential for the IT industry due to supportive government initiatives across all regions. The growing trend of preventive healthcare & the rise in funding for mHealth startups are other factors boosting the market.

Gather more insights about the market drivers, restrains and growth of the Digital Health Market

The rising incidence of chronic conditions such as diabetes, heart disease, and cancer is fueling the demand for remote monitoring and management solutions. Digital health tools can help patients track their health, adhere to treatment plans, and communicate with healthcare providers more effectively.

Global Digital Health Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest trends in each of the segments from 2018 to 2030. For this study, Grand View Research, Inc. has segmented the global digital health market report on the basis of technology, component, application, end-use, and region:

Technology Outlook (Revenue, USD Million, 2018 - 2030)

Tele-healthcare

Tele-care

Activity Monitoring

Remote Medication Management

Tele-health

LTC Monitoring

Video Consultation

mHealth

Wearables & Connected Medical Devices

Vital Sign Monitoring Devices

Heart Rate Monitors

Activity Monitors

Electrocardiographs

Pulse Oximeters

Spirometers

Blood Pressure Monitors

Others

Sleep Monitoring Devices

Sleep trackers

Wrist Actigraphs

Polysomnographs

Others

Electrocardiographs Fetal & Obstetric Devices

Neuromonitoring Devices

Electroencephalographs

Electromyographs

Others

mHealth Apps

Medical Apps

Women's Health

Fitness & Nutrition

Menstrual Health

Pregnancy Tracking & Postpartum Care

Menopause

Disease Management

Others

Chronic Disease Management Apps

Diabetes Management Apps

Blood Pressure & ECG Monitoring Apps

Mental Health Management Apps

Cancer Management Apps

Obesity Management Apps

Other Chronic Disease Management Apps

Personal Health Record Apps

Medication Management Apps

Diagnostic Apps

Remote Monitoring Apps

Others (Pill Reminder, Medical Reference, Professional Networking, Healthcare Education)

Fitness Apps

Services

Monitoring Services

Independent Aging Solutions

Chronic Disease Management & Post-Acute Care Services

Diagnosis Services

Healthcare Systems Strengthening Services

Others

Digital Health Systems

EHR

E-prescribing Systems

Healthcare Analytics

Component Outlook (Revenue, USD Million, 2018 - 2030)

Software

Hardware

Services

Application Outlook (Revenue, USD Million, 2018 - 2030)

Obesity

Diabetes

Cardiovascular

Respiratory Diseases

Others

End-use Outlook (Revenue, USD Million, 2018 - 2030)

Patients

Providers

Payers

Others

Regional Outlook (Revenue, USD Million, 2018 - 2030)

North America

US

Canada

Europe

UK

Germany

France

Italy

Spain

Sweden

Denmark

Norway

Asia Pacific

China

India

Japan

Australia

South Korea

Singapore

Latin America

Brazil

Mexico

Argentina

MEA

South Africa

Saudi Arabia

UAE

Kuwait

Browse through Grand View Research's Healthcare IT Industry Research Reports.

• The global computerized physician order entry market size was valued at USD 1.94 billion in 2023 and is projected to grow at a CAGR of 6.3% from 2024 to 2030.

• The global healthcare cloud computing market size was valued at USD 19.6 billion in 2023 and is projected to grow at a CAGR of 12.7% from 2024 to 2030.

Key Digital Health Company Insights

Key players are adopting new product development, partnership, and merger & acquisition strategies to increase their market share. Apple, Inc., Google, Inc., and Qualcomm Technologies, Inc. are market leaders with a presence in more than 30 countries, including headquarters, manufacturing sites, distribution centers, and office locations. The Apple App Store features over 40,000 apps in the healthcare segment. In March 2023, to improve digital health, Apple Inc. announced plans to upgrade AirPods by adding ambient light sensors with health tracking features, including motion detectors, temperature monitors, blood oxygen level, and perspiration & heart rate, by 2025. In addition, H2O Therapeutics, a Turkey-based startup, received U.S. FDA clearance for its Parky app. This Apple Watch app monitors Parkinson’s disease symptoms, such as dyskinesia and tremors. Furthermore, Samsung Electronics Co. Ltd., Qualcomm Technologies, Inc., and Vodafone Group Plc. are the emerging market players.

Key Digital Health Companies:

The following are the leading companies in the digital health market. These companies collectively hold the largest market share and dictate industry trends

Telefónica S.A.

Epic Systems Corporation

QSI Management, LLC

AT&T

AirStrip Technologies

Google, Inc.

Hims & Hers Health, Inc.

Orange

Softserve

Computer Programs and Systems, Inc.

Vocera Communications

IBM Corporation

CISCO Systems, Inc.

Apple Inc.

Oracle Cerner

Veradigm

Mckesson Corporation

Hims & Hers Health, Inc.

Vodafone Group

Qualcomm Technologies, Inc.

Samsung Electronics Co., Ltd.

Recent Developments

In April 2023, Microsoft collaborated with Epic Systems Corporation to integrate AI into EHR, enabling healthcare practitioners to improve their productivity and patient communication with AI-enabled solutions

In March 2023, BlueRock Therapeutics LP entered a collaboration with Emerald Innovations and Rune Labs with a major focus on innovations using contactless & invisible, wearable digital health technology to improve monitoring of Parkinson's disease

In March 2023, Google launched Open Health Stack, an open-source program for developers to build health-related apps by including strategies, such as AI partnerships focusing on cancer screening

In March 2023, Nabla Technologies launched Copilot, a digital assistant tool, as a Chrome extension using GPT-3 for doctors to make patients' conversations turn into action

In March 2022, Samsung unveiled its latest innovation, a smart healthcare TV and advanced digital health solutions for healthcare facilities, at the Healthcare Information and Management Systems Society (HIMSS) Global Conference in Florida. Furthermore, Samsung and ShareSafe partnered to develop a secure solution for casting from mobile devices to Samsung Smart Healthcare TV

In March 2022, Epic Systems Corporation launched Garden Plot, which provides small independent healthcare groups access to Epic software solutions and an interoperability network

In March 2022, Vocera Communications, a part of Stryker, introduced Minibadge. This compact, portable, voice-driven wearable device integrates with clinical and operational workflows of healthcare facilities & enables hands-free communication.

Order a free sample PDF of the Digital Health Market Intelligence Study, published by Grand View Research.

[amrutatbrc1]

Pulmonology Devices Market 2024 : Industry Analysis, Trends, Segmentation, Regional Overview And Forecast 2033

Overview and Scope Pulmonology devices are medical instruments and equipment used in the diagnosis, treatment, and management of respiratory system conditions and diseases. These devices play a crucial role in assessing lung function, monitoring respiratory health, providing therapeutic interventions, and supporting patients with respiratory disorders.

Sizing and Forecast The pulmonary devices market size has grown rapidly in recent years. It will grow from $1.23 billion in 2023 to $1.36 billion in 2024 at a compound annual growth rate (CAGR) of 10.6%. The growth in the historic period can be attributed to rising incidence of chronic respiratory diseases, growing shift towards preventive healthcare, increase in adoption of pulmonology devices, surge in incidence of diseases requiring endoscopic ultrasound procedures, increase in geriatric population.

The pulmonary devices market size is expected to see rapid growth in the next few years. It will grow to $2.05 billion in 2028 at a compound annual growth rate (CAGR) of 10.8%. The growth in the forecast period can be attributed to rise in prevalence of respiratory diseases, rising air pollution levels, growth in home healthcare, growing awareness and early diagnosis, expansion of healthcare infrastructure. Major trends in the forecast period include integration of artificial intelligence, growth of telemedicine and remote monitoring, advancements in portable and wearable devices, use of robotic technology in less-invasive diagnostic procedures, increase in home care services.

Order your report now for swift delivery, visit the link: https://www.thebusinessresearchcompany.com/report/pulmonology-devices-global-market-report

Segmentation & Regional Insights The pulmonology devices market covered in this report is segmented ��

1) By Product Type: Endobronchial Ultrasound (EBUS) Needles, Pulmonary Biopsy Devices, Airway Stents, Single-Use Bronchoscopes, Other Product Types 2) By Indication: Chronic Obstructive Pulmonary Disease (COPD), Lung Cancer, Tracheal And Bronchial Stenosis, Foreign Body Extraction, Other Indications 3) By End-User: Pulmonology Clinics, Hospitals, Ambulatory Surgical Centers

North America was the largest region in the pulmonology devices market in 2023. The regions covered in the pulmonology devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Intrigued to explore the contents? Secure your hands-on a free sample copy of the report: https://www.thebusinessresearchcompany.com/sample.aspx?id=16772&type=smp

Major Driver Impacting Market Growth The rise in the prevalence of respiratory diseases is expected to propel the growth of the pulmonology devices market going forward. Respiratory diseases are a group of medical conditions that affect the organs and tissues involved in breathing, including the airways, lungs, and respiratory muscles. The cases of respiratory diseases are occurring due to rising air pollution, smoking, and occupational hazards. Pulmonology devices aid in respiratory disease management by enabling accurate diagnosis, continuous monitoring, and effective treatment through tools like spirometers, inhalers, pulse oximeters, and ventilators, ultimately improving patient outcomes and quality of life. For instance, according to the Scottish Public Health Observatory, a Scotland-based public health agency, COPD rates began rising in 2021-22 as the effects of COVID-19 lessened. The rate among males rose from 83.2 to 97.6 cases per 100,000, while it increased from 72.6 to 97.3 among females. Therefore, the rise in the prevalence of respiratory diseases is driving the growth of the pulmonology devices market.

Key Industry Players Major companies operating in the pulmonology devices market are Medtronic, Koninklijke Philips N.V., GE Healthcare, Baxter, Boston Scientific Corporation, Medline Industries LP., Olympus Corporation, Omron Healthcare, ResMed, Getinge, ICU Medical Inc., Fisher & Paykel Healthcare Limited, Ambu A/S, Vyaire Medical Inc., Drive DeVilbiss Healthcare, PENTAX Medical, Hamilton Medical, Nonin Medical, CAIRE Inc., Pulmonx Corporation, Verathon Inc., Draegerwerk AG & Co. KGaA, NIOX

The pulmonology devices market report table of contents includes:

1. Executive Summary

2. Pulmonology Devices Market Characteristics

3. Pulmonology Devices Market Trends And Strategies

4. Pulmonology Devices Market - Macro Economic Scenario

5. Global Pulmonology Devices Market Size and Growth ..........

32. Global Pulmonology Devices Market Competitive Benchmarking

33. Global Pulmonology Devices Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Pulmonology Devices Market

35. Pulmonology Devices Market Future Outlook and Potential Analysis

36. Appendix

Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: info@tbrc.info

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info/

Healthcare Blog: https://healthcareresearchreports.com/

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

[healthtech-katta]

Advancements in Spirometer Technology Enhance Respiratory Health Management

The field of respiratory health management has seen significant improvements with recent advancements in spirometer technology. Spirometers, essential tools used to assess lung function by measuring the volume and flow of air that a person can inhale and exhale, are now more accurate, portable, and user-friendly than ever before. These developments are proving crucial in diagnosing, monitoring, and managing chronic respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), and other lung disorders.

Enhanced Accuracy and Sensitivity

Modern spirometers have become highly accurate, capable of detecting even the slightest variations in lung function. With improved sensors and digital technology, these devices can provide more precise measurements of key respiratory parameters such as Forced Vital Capacity (FVC) and Forced Expiratory Volume in one second (FEV1). This level of sensitivity is particularly beneficial for early detection of respiratory issues, allowing for timely intervention and treatment.

The Spirometer Market size is valued at USD 1.12 Bn in 2023 and is expected to reach USD 2.39 Bn by 2031 with a growing CAGR of 10.17% over the forecast period of 2024-2031.

Portability and Remote Monitoring

The latest spirometer models are designed with portability in mind, making it easier for patients to monitor their lung function at home or on the go. These compact, lightweight devices often connect to smartphones or tablets, enabling real-time data transfer to healthcare providers. This capability is especially valuable in the current era of telemedicine, where remote monitoring and virtual consultations have become more common. Patients can now manage their respiratory health more proactively, with fewer visits to the clinic.

User-Friendly Interfaces and Data Integration

Advancements in spirometer technology have also focused on improving the user experience. Many devices now feature intuitive interfaces that guide patients through the testing process, reducing the likelihood of errors and ensuring consistent results. Additionally, the integration of spirometer data with electronic health records (EHRs) and other digital health platforms allows for seamless tracking of a patient’s respiratory health over time. Healthcare providers can easily access and analyze this data, facilitating more informed decision-making and personalized care plans.

The Future of Spirometry

Looking forward, the future of spirometry holds exciting possibilities. Researchers are exploring the development of spirometers with advanced AI-driven algorithms that can automatically interpret results and provide immediate feedback. Furthermore, innovations in wearable technology could lead to the creation of continuous monitoring systems, offering a more comprehensive view of a patient’s respiratory function in real-time.

As spirometer technology continues to evolve, it promises to play an increasingly vital role in respiratory health management. These advancements not only improve the accuracy and ease of lung function testing but also empower patients to take a more active role in their healthcare, ultimately leading to better outcomes and quality of life.

[secretofresearch]

Respiratory Devices Market is Poised to Experience Strong Growth on Account of Rising Prevalence of Respiratory Diseases

The respiratory devices market is growing rapidly owing to the rising prevalence of respiratory diseases across the globe. Respiratory devices include diagnostic devices such as spirometers, pulse oximeters, peak flow meters; therapeutic devices including nebulizers, humidifiers, and oxygen concentrators. These devices are used for the diagnosis and treatment of respiratory diseases like asthma, chronic obstructive pulmonary diseases (COPD), and sleep apnea. The increasing awareness about respiratory care, accessibility and affordability of devices are fueling the growth of the market. The rapidly aging population and high pollution levels are also contributing to the rising incidences of respiratory illnesses.

The global respiratory devices market is estimated to be valued at USD 23.58 Bn in 2024 and is expected to reach USD 48.94 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 11% from 2024 to 2031.

Key Takeaways

Key players operating in the respiratory devices market are TCS, Wipro, Cognizant, Infosys, IBM, Qualitest, CGI, Mindtree, Cygnet Infotech, Maveric Systems, QA Mentor, A1QA, QA Source, QASource, Capgemini, Accenture, HCL Technologies, Atos, DXC Technology, Tech Mahindra. The growing prevalence of respiratory diseases and increasing awareness regarding respiratory care are fueling the demand for respiratory devices globally. Major players in the market are focusing on expanding their geographical footprint to tap the opportunities in emerging markets.

The key players in the Respiratory Devices Market Size are focusing on new product launches and strategic collaborations to strengthen their market position. The growing demand for home care therapeutic and diagnostic devices is driving major players to innovate compact portable devices for home settings.

The increasing global burden of respiratory diseases is propelling the demand for respiratory devices across regions. Key players are expanding their manufacturing and distribution networks in developing countries to cater to the rising demand.

Market Key Trends

One of the key trends gaining traction in the respiratory devices market is the increasing preference for wireless and portable devices. Major players are innovating compact portable devices integrated with advanced technologies like Bluetooth for seamless monitoring and management of respiratory illnesses from home settings. This is expected to drive the uptake of respiratory devices for home healthcare. Furthermore, the growing focus on telehealth and digital health presents lucrative opportunities for market players to offer virtual monitoring and consultation solutions using connected respiratory devices.

Porter's Analysis

Threat of new entrants: The respiratory devices market requires high capital investment and R&D spending. Strict regulations by governmental bodies for new entrants pose barriers.

Bargaining power of buyers: Individual buyers have low bargaining power due to undifferentiated products. However, large healthcare providers and public/private insurers enjoy high bargaining power due to bulk purchasing.

Bargaining power of suppliers: The respiratory devices market has high dependence on few raw material suppliers and component manufacturers. This increases their bargaining power.

Threat of new substitutes: Alternatives such as drug therapies provide a minimal threat currently. However, new non-invasive technologies can emerge as substitutes.

Competitive rivalry: The market is dominated by global key players. Intense competition exists in areas of innovation, quality, and cost.

Geographical Regions

Value concentration of the respiratory devices market is highest in North America due to increasing geriatric population, prevalence of respiratory diseases, and availability of advanced healthcare facilities. Europe accounts for the second largest share due to high smoking population and strategic initiatives undertaken by government and industry players.

Asia Pacific region is the fastest growing market for respiratory devices driven by factors such as growing burden of respiratory diseases, increasing aged population, rising healthcare expenditures, and focus of global players to tap into emerging countries. China and India are viewed as highly potential markets in the Asia Pacific respiratory devices space.

Get more insights on Respiratory Devices Market

About Author:

Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)

[aishavass]

Asia Pacific region is anticipated to witness highest growth rate owing to rising demand for spirometers from emerging economies such as Japan, China, and...

[health-views-updates]

Spirometer Market Trends Global Industry Analysis, Top Manufacturers, Growth, Opportunities & Forecast to 2031

The global spirometer market has witnessed substantial growth in recent years and is expected to continue its upward trajectory in the coming years. According to recent reports, the market size was valued at USD 1.12 billion in 2023 and is projected to reach USD 2.39 billion by 2031, with a compound annual growth rate (CAGR) of 10.17% during the forecast period of 2024-2031. This remarkable growth can be attributed to various key drivers, emerging trends, and opportunities within the market.

Key Drivers Propelling Growth:

Increasing Respiratory Disorders: With the rising prevalence of respiratory diseases such as chronic obstructive pulmonary disease (COPD), asthma, and cystic fibrosis, there is a growing demand for diagnostic tools like spirometers. These devices play a crucial role in assessing lung function, aiding in the diagnosis, management, and monitoring of respiratory conditions.

Technological Advancements: The spirometer market has witnessed significant advancements in technology, leading to the development of portable, user-friendly devices with enhanced accuracy and efficiency. Integration of wireless connectivity, cloud-based data storage, and mobile applications has further improved patient accessibility and convenience.

Growing Awareness and Screening Programs: Increasing awareness about the importance of early detection and management of respiratory disorders, coupled with government initiatives and healthcare campaigns, has resulted in a higher rate of screening for lung function abnormalities. This, in turn, has boosted the demand for spirometry testing, driving market growth.

Aging Population and Lifestyle Changes: The aging population, along with changing lifestyles characterized by factors such as smoking, sedentary behavior, and environmental pollution, has contributed to the rising incidence of respiratory ailments. As a result, there is a greater need for respiratory care devices like spirometers to cater to this demographic segment.

Download Free Sample Report: https://www.snsinsider.com/sample-request/2987

Emerging Trends and Opportunities:

Telemedicine and Remote Monitoring: The adoption of telemedicine and remote patient monitoring solutions has gained traction, especially in the wake of the COVID-19 pandemic. Spirometers equipped with telehealth capabilities allow healthcare providers to remotely monitor patients' lung function and adjust treatment plans accordingly, presenting significant growth opportunities in the market.

Point-of-Care Testing: The shift towards point-of-care testing (POCT) has led to the development of compact, handheld spirometers that can deliver rapid results outside traditional clinical settings. These devices offer convenience, portability, and real-time data analysis, catering to the growing demand for decentralized healthcare solutions.

Integration of Artificial Intelligence (AI): AI-powered spirometry systems are being developed to improve diagnostic accuracy and streamline data interpretation. Machine learning algorithms can analyze spirometry results, detect patterns, and provide insights that aid clinicians in making informed decisions regarding patient care.

Challenges and Considerations:

Cost Constraints: The high cost associated with spirometry equipment, particularly advanced models with integrated features, may limit market penetration, especially in developing regions with constrained healthcare budgets. Manufacturers need to focus on product affordability and cost-effectiveness to address this challenge.

Regulatory Compliance: Stringent regulatory requirements governing the manufacture and sale of medical devices pose challenges for market players in terms of compliance and product approvals. Ensuring adherence to quality standards and navigating regulatory frameworks is essential for market success.

Data Security and Privacy Concerns: With the increasing adoption of digital health technologies, safeguarding patient data privacy and ensuring cybersecurity are critical considerations. Spirometry devices that incorporate data transmission and storage capabilities must implement robust security measures to protect sensitive information from unauthorized access or breaches.

Key Takeaways from the Market:

The global spirometer market is witnessing robust growth, driven by factors such as increasing respiratory disorders, technological advancements, and growing awareness.

Opportunities abound in emerging trends such as telemedicine, point-of-care testing, and AI integration, offering innovative solutions for respiratory care.

Addressing challenges related to cost constraints, regulatory compliance, and data security is imperative for sustained market growth and competitiveness.

Collaboration between healthcare stakeholders, including manufacturers, healthcare providers, and regulatory bodies, is essential for driving innovation, ensuring quality, and delivering optimal patient outcomes in the spirometer market.